Archive · 28 Jul 2025
DNB Carnegie Leads European IPOs Amidst Nordic Listings Boom
Imagine companies wanting to sell shares to the public to raise money.
In Europe, a bank called DNB Carnegie is helping these companies do this, especially in the Nordic countries like Sweden.
The Nordic market is doing really well, unlike places like London.
DNB Carnegie has helped raise about $2 billion this year through these sales, making them the top bank in Europe for these kinds of deals.
They're seeing success because local investors and retail investors are eager to participate.
To make sure things go smoothly, companies are carefully planning their sales to investors.
While the market is generally strong, some companies have delayed their plans due to uncertain conditions.
DNB Carnegie is Europe's leading IPO underwriter in 2025, based on deal volume.
The Nordic market, particularly Stockholm, is booming compared to other European financial centers.
DNB Carnegie worked on five IPOs this year, raising roughly $2 billion in proceeds.
Verisure's planned Swedish listing could potentially raise €3 to €4 billion.
Newly listed companies are using smaller free-floats and shorter offering periods to mitigate risks.
- Who
- DNB Carnegie is the leading underwriter, with companies like Asker Healthcare Group AB and Verisure involved.
- What
- DNB Carnegie has become Europe's leading underwriter of initial public offerings.
- When
- The trend is observed in 2025, after the second half of 2024.
- Where
- The Nordic region, especially Stockholm, is experiencing significant IPO activity, while other European financial centers have lagged.
- Why
- The strength of the Nordic market is attributed to its local asset managers, pension funds and retail investors.
- Leading Underwriter
- DNB Carnegie
- Total IPO Proceeds (approx.)
- $2 billion
- Leading Market
- Stockholm
- Largest IPO (2025)
- Asker Healthcare Group AB ($1 billion)
- Verisure Planned Listing
- €3 to €4 billion
- Retail Investor Participation
- Around 10% of allocations on average